USFDA Issues Post-Application Action Letter to Dr Reddy’s Biologics Unit
Hyderabad: Dr. Reddy's Laboratories Ltd has received a Post-Application Action Letter (PAAL) from the United States Food and Drug Administration (USFDA) following the regulator's review of the company's response to…
